|
CSF Aβ/ptau Summary Statistics - Deming Y et al. (2017) |
|
|
|
|
Similar Genetic Architecture of Alzheimer’s Disease and Differential APOE Effect Between Sexes- Wang et al. 2021 |
|
|
|
|
CSF TREM2 Summary Statistics |
|
|
|
|
Large scale CSF proteogenomic atlas (via DSS) |
|
|
|
|
The Prediction of Alzheimer’s Disease through Multi-Trait Genetic Modeling (via DSS) |
|
|
|
|
Resolving mutations in challenging genomic regions to test association with disease phenotypes (via DSS) |
|
|
|
|
Sex differences in the genetic predictors of Alzheimer’s pathology – Dumitrescu et al., 2019 (via DSS) |
|
|
|
|
Transethnic GWAS Summary Statistics - Jun et al. (2017) |
|
|
|
|
Results of gene-based weighted burden analyses using SCOREASSOC and GENEVARASSOC applied to the ADSP discovery sample |
|
|
|
|
Large scale genetics study on CSF and brain metabolite levels (via DSS) |
|
|
|
|
Progressive Supranuclear Palsy (PSP) Summary Statistics- Hoglinger et al. (2011) |
|
|
|
|
IGAP APOE-Stratified Analysis Summary Statistics- Jun et al. (2015) |
|
|
|
|
Longitudinal Change in Memory Performance as a Strong Endophenotype for Alzheimer’s – Archer, et al, 2023 (via DSS) |
|
|
|
|
UAB/HudsonAlpha Families with Neurodegenerative Diseases |
|
|
|
|
Sex-specific genetic architecture of late-life memory performance (via DSS) |
|
|
|
|
Summary Statistics of IGAP Age at onset survival GWAS dataset - Huang KL et al. (2017) |
|
|
|
|
Safety and pharmacokinetics of a highly bioavailable resveratrol preparation(JOTROL TM) (via DSS) |
|
|
|
|
ADGC Age at Onset Summary Statistics- Naj et al. (2014) |
|
|
|
|
Circular RNAs in Alzheimer Disease Brains - RNA-seq Data |
|
|
|
|
Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease – Eissman et al., 2022 (via DSS) |
|
|
|
